J Dehais

1.7k total citations
44 papers, 1.1k citations indexed

About

J Dehais is a scholar working on Rheumatology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J Dehais has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Rheumatology, 9 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J Dehais's work include Rheumatoid Arthritis Research and Therapies (6 papers), Systemic Lupus Erythematosus Research (5 papers) and Inflammatory mediators and NSAID effects (5 papers). J Dehais is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (6 papers), Systemic Lupus Erythematosus Research (5 papers) and Inflammatory mediators and NSAID effects (5 papers). J Dehais collaborates with scholars based in France, Belize and New Zealand. J Dehais's co-authors include Thierry Schaeverbeke, B Bannwarth, Fabienne Péhourcq, T. Schaeverbeke, Vincent Dousset, Christophe Richez, Patrick Blanco, Mario Ries, Jean‐Marie Caillé and Pierre Arné and has published in prestigious journals such as PLoS ONE, Neurology and Radiology.

In The Last Decade

J Dehais

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Dehais France 17 333 319 202 196 186 44 1.1k
C. G. Barnes United Kingdom 18 614 1.8× 146 0.5× 73 0.4× 91 0.5× 92 0.5× 40 1.5k
Markus R. John Switzerland 22 552 1.7× 441 1.4× 275 1.4× 59 0.3× 61 0.3× 45 2.1k
Stefan M. Weiner Germany 21 495 1.5× 220 0.7× 274 1.4× 30 0.2× 201 1.1× 56 1.4k
Sheetal Desai United States 9 219 0.7× 180 0.6× 95 0.5× 50 0.3× 63 0.3× 16 1.2k
A. Veihelmann Germany 19 126 0.4× 468 1.5× 230 1.1× 209 1.1× 53 0.3× 49 1.0k
Fumio Terasaki Japan 29 120 0.4× 267 0.8× 66 0.3× 52 0.3× 73 0.4× 109 2.1k
Wallace G. Campbell United States 25 175 0.5× 429 1.3× 95 0.5× 42 0.2× 40 0.2× 66 1.8k
F. T. Fraunfelder United States 20 99 0.3× 84 0.3× 92 0.5× 78 0.4× 277 1.5× 57 1.5k
George Moxley United States 20 507 1.5× 80 0.3× 80 0.4× 115 0.6× 173 0.9× 37 1.5k
Hua Jiang China 21 176 0.5× 379 1.2× 406 2.0× 177 0.9× 79 0.4× 77 1.5k

Countries citing papers authored by J Dehais

Since Specialization
Citations

This map shows the geographic impact of J Dehais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Dehais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Dehais more than expected).

Fields of papers citing papers by J Dehais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Dehais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Dehais. The network helps show where J Dehais may publish in the future.

Co-authorship network of co-authors of J Dehais

This figure shows the co-authorship network connecting the top 25 collaborators of J Dehais. A scholar is included among the top collaborators of J Dehais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Dehais. J Dehais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richez, Christophe, Thierry Schaeverbeke, Chantale Dumoulin, et al.. (2009). Myeloid dendritic cells correlate with clinical response whereas plasmacytoid dendritic cells impact autoantibody development in rheumatoid arthritis patients treated with infliximab. Arthritis Research & Therapy. 11(3). R100–R100. 24 indexed citations
2.
Rambert, Jérôme, Maria Mamani‐Matsuda, Daniel Moynet, et al.. (2009). Molecular Blocking of CD23 Supports Its Role in the Pathogenesis of Arthritis. PLoS ONE. 4(3). e4834–e4834. 18 indexed citations
3.
Dumoulin, Chantale, et al.. (2006). Peripheral neuropathy associated with leflunomide: is there a risk patient profile?. Pharmacoepidemiology and Drug Safety. 16(1). 74–78. 20 indexed citations
4.
Dumoulin, Chantale, et al.. (2005). Effectiveness and safety profile of leflunomide in rheumatoid arthritis: actual practice compared with clinical trials.. PubMed. 23(1). 80–4. 16 indexed citations
5.
Schaeverbeke, Thierry, et al.. (2005). Densité minérale et métabolisme osseux des spondylarthropathies. La Revue de Médecine Interne. 26(5). 381–385. 1 indexed citations
6.
Demir, Ayhan S., Mario Ries, Jean-Marc Vital, et al.. (2003). Diffusion-weighted MR Imaging with Apparent Diffusion Coefficient and Apparent Diffusion Tensor Maps in Cervical Spondylotic Myelopathy. Radiology. 229(1). 37–43. 190 indexed citations
7.
Bannwarth, B, Philippe Bertin, Fabienne Péhourcq, et al.. (2001). Piroxicam concentrations in plasma and synovial fluid after a single dose of piroxicam-b-cyclodextrin. International Journal of Clinical Pharmacology and Therapeutics. 39(1). 33–36. 11 indexed citations
8.
Germain, Pierre, et al.. (2001). Cholesterol crystal embolization simulating focal myositis. Joint Bone Spine. 68(3). 267–269.
9.
Delbrel, X., Thierry Schaeverbeke, François Lifermann, & J Dehais. (2001). Arthropathy associated with anti-Jo-1 antibody. Joint Bone Spine. 68(2). 166–169. 7 indexed citations
10.
Schaeverbeke, T., et al.. (1999). Chondrosarcoma in a patient with McCune-Albright syndrome. Report of a case.. PubMed. 66(3). 177–9. 11 indexed citations
11.
Bourgeois, Pierre, Gérard Chalès, J Dehais, et al.. (1998). Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3×400 mg/day vs placebo. Osteoarthritis and Cartilage. 6. 25–30. 87 indexed citations
12.
Schaeverbeke, Thierry, et al.. (1997). Les facteurs d'environnement et les éléments iatrogènes dans la sclérodermie systémique et les syndromes apparentés. Revue de la littérature. La Revue de Médecine Interne. 18(3). 219–229. 12 indexed citations
13.
Huec, J. C. Le, et al.. (1996). Traumatic tear of the rotator interval. Journal of Shoulder and Elbow Surgery. 5(1). 41–46. 53 indexed citations
14.
Lafage–Proust, Marie-Hélène, Thierry Schaeverbeke, & J Dehais. (1996). Fibrogenesis Imperfecta Ossium: Ineffectiveness of Melphalan. Calcified Tissue International. 59(4). 240–244. 10 indexed citations
15.
Bannwarth, B, Fabienne Péhourcq, Thierry Schaeverbeke, & J Dehais. (1996). Clinical Pharmacokinetics of Low-Dose Pulse Methotrexate in Rheumatoid Arthritis. Clinical Pharmacokinetics. 30(3). 194–210. 159 indexed citations
16.
Bannwarth, B, F. Lapicque, Fabienne Péhourcq, et al.. (1995). Stereoselective disposition of ibuprofen enantiomers in human cerebrospinal fluid.. British Journal of Clinical Pharmacology. 40(3). 266–269. 50 indexed citations
17.
Bannwarth, B, F. Demotes‐Mainard, T. Schaeverbeke, & J Dehais. (1993). Where are peripheral analgesics acting?. Annals of the Rheumatic Diseases. 52(1). 1–4. 20 indexed citations
18.
Dehais, J, et al.. (1983). [Results of a regional survey on the treatment of rhizomelic pseudopolyarthritis and temporal arteritis. Apropos of 242 cases treated by various modalities with synthetic antimalarials, corticoids and non-steroidal anti-inflammatory agents].. PubMed. 50(8-9). 563–71. 12 indexed citations
19.
Dehais, J, et al.. (1978). Manifestations articulaires au cours de deux cas de lèpre.. 45(5).
20.
Dehais, J, et al.. (1976). [Multicentric reticulohistiocytosis (lipoid dermato-arthritis). Apropos of a case with fatal outcome].. PubMed. 43(2). 123–32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. G. Barnes Breakdown of academic impact, for papers by Markus R. John Breakdown of academic impact, for papers by Stefan M. Weiner Breakdown of academic impact, for papers by Sheetal Desai Breakdown of academic impact, for papers by A. Veihelmann Breakdown of academic impact, for papers by Fumio Terasaki Breakdown of academic impact, for papers by Wallace G. Campbell Breakdown of academic impact, for papers by F. T. Fraunfelder Breakdown of academic impact, for papers by George Moxley Breakdown of academic impact, for papers by Hua Jiang
Rankless by CCL
2026